MAPT and Alzheimer disease: While APOEε3 typically maintains lipid homeostasis without significantly affecting AD progression [32], some rare variants (e.g., APOE3-Jac, APOE3ch) may paradoxically reduce AD risk by enhancing microglial clearance of tau pathology, suppressing neuroinflammation, and mitigating amyloid β toxicity [33,34].